Position in MGNX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$17,374,680
+$7,193,040 QoQ
Shares Held
6,012,000
-4.9% QoQ
Ownership
9.46%
of shares outstanding
% of Portfolio
0.57%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MGNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ARMISTICE CAPITAL, LLC holds $1,388,824,976 across 55 Biotechnology names. MGNX ranks #24 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TVTX |
Travere Therapeutics, Inc.
|
4,897,417 | $145,502,259 | |
| 2 | PTCT |
Ptc Therapeutics, Inc.
|
2,074,449 | $141,332,210 | |
| 3 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
264,583 | $138,501,263 | |
| 4 | AGIO |
Agios Pharmaceuticals, Inc.
|
2,716,000 | $91,882,280 | |
| 5 | IMVT |
Immunovant, Inc.
|
3,564,916 | $88,552,513 | |
| 6 | INCY |
Incyte Corp
|
656,817 | $61,819,616 | |
| 7 | DYN |
Dyne Therapeutics, Inc.
|
3,175,110 | $57,564,744 | |
| 8 | CYTK |
Cytokinetics Inc
|
764,538 | $50,390,699 |
All Filings in MGNX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $17,374,680 | 6,012,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $10,181,640 | 6,324,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $10,012,800 | 5,960,000 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $7,211,600 | 5,960,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $7,995,920 | 6,296,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $20,397,000 | 6,276,000 | Shares | Sole | 2025-02-14 | |
| 2024-12-31 | $20,397,000 | 6,276,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $20,588,820 | 6,258,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $25,500,000 | 6,000,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $35,328,000 | 2,400,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $43,982,640 | 4,572,000 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $21,957,920 | 4,712,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $29,960,000 | 5,600,000 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $42,733,200 | 5,960,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $40,877,320 | 6,092,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $21,202,880 | 6,128,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $18,077,600 | 6,128,000 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $44,050,000 | 5,000,000 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $43,335,000 | 2,700,000 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||